World's Best Scientists 2026 revealed!
Rodolphe Thiébaut

Rodolphe Thiébaut

D-Index & Metrics

Microbiology

D-Index
73
Citations
23518
World Ranking
1632
National Ranking
97

Rodolphe Thiébaut publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Rodolphe Thiébaut sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 326 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Rodolphe Thiébaut D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Rodolphe Thiébaut sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Rodolphe Thiébaut is affiliated with the University of Bordeaux in France and has made significant contributions to the field of medicine, with a focus on infectious diseases. Their research encompasses several subfields such as infectious diseases, molecular biology, epidemiology, modeling and simulation, as well as statistics and probability.

Thiébaut's work spans multiple topics, notably including:

  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 research
  • Viral infections and outbreaks research
  • COVID-19 clinical research studies
  • Single-cell and spatial transcriptomics
  • Immunotherapy and immune responses
  • Data-driven disease surveillance

They have frequently published in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature Communications
  • Research Square
  • arXiv (Cornell University)

Thiébaut has co-authored numerous papers with recurring collaborators including Boris P. Hejblum, Mélanie Prague, Christine Lacabaratz, Yves Lévy, and Aurélie Wiedemann.

Among their recent publications are:

  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial (2020, The Lancet Infectious Diseases)
  • CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2021, iScience)
  • Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data (2021, Nature Communications)
  • Long-lasting severe immune dysfunction in Ebola virus disease survivors (2020, Nature Communications)
  • Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa (2021, PLoS Medicine)

Best Publications

  • Combination antiretroviral therapy and the risk of myocardial infarction

    Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte

  • Class of antiretroviral drugs and the risk of myocardial infarction.

    Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber

  • Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

    Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut

  • Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination

    David Furman;Boris P. Hejblum;Noah Simon;Vladimir Jojic

  • Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

    Smith C;Sabin Ca;Lundgren Jd

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

    Nina Friis-Møller;Rodolphe Thiébaut;Peter Reiss;Rainer Weber

  • Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

    May M;Sterne Ja;Sabin C;Costagliola D

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D : A : D Study

    M G Law;N Friis-Møller;W M El-Sadr;R Weber

  • Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

    M Law;N Friis-Møller;R Weber;P Reiss

  • Effectiveness of disease-management programs for improving diabetes care: a meta-analysis

    C Pimouguet;M Le Goff;R Thiebaut;JF Dartigues

  • Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

    Benoît Marin;Rodolphe Thiébaut;Heiner C. Bucher;Virginie Rondeau

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

    Elise Arrivé;Marie-Louise Newell;Didier K Ekouevi;Marie-Laure Chaix

  • Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.

    Charles Cazanave;Michel Dupon;Valérie Lavignolle-Aurillac;Nicole Barthe

  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

    Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  • Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines

    Sara Lodi;Andrew Phillips;Giota Touloumi;Ronald Geskus

Frequent Co-Authors

Geneviève Chêne
Geneviève Chêne University of Bordeaux
François Dabis
François Dabis University of Bordeaux
Daniel Commenges
Daniel Commenges University of Bordeaux
Peter Reiss
Peter Reiss University of Amsterdam
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Caroline Sabin
Caroline Sabin University College London
Philippe Morlat
Philippe Morlat University of Bordeaux
Fabrice Bonnet
Fabrice Bonnet University of Rennes
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Andrew N. Phillips
Andrew N. Phillips University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career paths, some of which intersect with the expanding healthcare and information management sectors. For those interested in combining biological sciences with administrative skills, becoming a certified professional coder (CPC) is a promising option. This role involves translating medical records into standardized codes essential for billing and data analysis.

Health information management is another critical field supporting the medical industry, focusing on patient data and healthcare systems optimization. Individuals can explore the best online health information management degree CAHIIM accredited programs to gain credentials recognized nationwide.

Professionals aiming for leadership roles may seek the qualifications to become a health information manager salary reflects the growing demand for those skilled in managing healthcare data and compliance.

For a quicker entry into healthcare support roles, accelerated courses are available. Students can consider enrolling in an accelerated medical billing and coding certificate online program to rapidly gain essential skills and certifications needed for employment.

Best Scientists Citing Rodolphe Thiébaut

Trending Scientists

Recently Published Articles